TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹445 Cr | ₹393 Cr | ₹369 Cr | ₹370 Cr | ₹338 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹445 Cr |
Mar2023 | ₹393 Cr |
Mar2022 | ₹369 Cr |
Mar2021 | ₹370 Cr |
Mar2020 | ₹338 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹445 Cr | 13.14 | |
Mar2023 | ₹393 Cr | 6.60 | |
Mar2022 | ₹369 Cr | -0.24 | |
Mar2021 | ₹370 Cr | 9.25 | |
Mar2020 | ₹338 Cr | - |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹109,504.5 Cr | -0.6% | 0.4% | 28.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹428,725.0 Cr | 2.5% | 0.2% | 17.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,525.0 Cr | 2.1% | 3.7% | 66.4% | Stock Analytics | |
CIPLA | ₹123,206.0 Cr | 0.9% | 0.1% | 14.6% | Stock Analytics | |
MANKIND PHARMA | ₹105,276.0 Cr | -1.2% | 5.6% | 11.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,927.5 Cr | -0.3% | -2.2% | -0.1% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.6% |
0.4% |
28.3% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses